Stockreport

Silence Therapeutics Presents Promising Phase 1 Data in Polycythemia Vera Patients at the American Society of Hematology (ASH) Annual Meeting

Silence Therapeutics Plc - American Depository Share  (SLN) 
PDF New divesiran data continue to show substantial reduction in phlebotomy frequency and lowering of hematocrit levels in PV patientsSilence also announces first subject do [Read more]